NSPR

Insider Trades

Name	Value	Action	Price	Current Price
Stuka PaulDirector $18k20k shares BuyMay 27, 2026 $0.875 --
Gleason Shane ThomasChief Commercial Officer $23k22.8k shares SellMay 19, 2026 $1.01 --
Gleason Shane ThomasChief Commercial Officer $23k22.8k shares SellMay 19, 2026 $1.01 --
Stuka PaulDirector $5.8k5k shares BuyMay 14, 2026 $1.15 --
Stuka PaulDirector $12k10k shares BuyMay 13, 2026 $1.16 --
Slosman MarvinDirector, Officer: CEO And President $25k21k shares BuyMay 12, 2026 $1.20 --

News

globenewswire.comInspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Proceduresglobenewswire.comJun 11

globenewswire.comInspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Proceduresglobenewswire.comJun 8

seekingalpha.comInspireMD, Inc. (NSPR) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcriptseekingalpha.comMay 13

globenewswire.comInspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conferenceglobenewswire.comMay 6

zacks.comInspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimateszacks.comMay 4

Trade NSPR

About InspireMD, Inc.

InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.

CEO: Marvin L. Slosman
IPO Date: Apr 12, 2011

Market Data

Open: $0.7504
High: $0.80
Low: $0.73
Volume: 97.9K
52W High: $2.93
52W Low: $0.72

Valuation

Market Cap: $35M
Enterprise Value: $25M

Financials

Free Cash Flow: $-37M
Revenue: $9.0M
Net Income: $-49M
Cash: $8.9M
Debt: $2.2M

Events

EarningsAug 3

EPS est. -0.2